Campbell, CA, May 28 2019 – Dark Horse Consulting Group, the leading global consultancy practice specializing in cell and gene therapy product development, will participate in the 2019 International Society for Cell and Gene Therapy Annual Meeting during May 29 – June 1, 2019 in Melbourne, Australia.
Katy Spink, Ph.D., Managing Partner and COO of Dark Horse Consulting Group, will present an oral communication in SFC Track Session 7 entitled ‘Regional Manufacturing Resourcing for Global Commercialization Strategies’ during the main conference on Saturday June 1st in Room 219.
“The ISCT Annual Meeting brings together Cell and Gene Therapy thought leaders from around the globe. DHC is proud to be contributing to this well attended, and very highly regarded event,” said Dr Spink.
The International Society for Cell Therapy Annual meeting is a four-day conference featuring presentations by leading commercial organizations in the field, along with representation from the world’s leading academic institutions. The annual ISCT meeting brings together global key opinion leaders with academics and clinicians from around the world, with the aim of advancing the industry to deliver more cures to patients.
About Dark Horse Consulting Group
Dark Horse Consulting Group specializes in the development of cell and gene therapy products. All of our consultants have deep cell and gene therapy industry experience, spanning diverse functions including process development, device development, manufacturing, quality, regulatory, program management, nonclinical, business development, strategy, and financing/investor relations. Many of our consultants also bring experience from adjacent more mature sectors, including traditional biologics, small molecules, medical devices, and management consulting. As a result, we deeply understand the unique challenges faced by cell and gene therapy developers and are able to apply best practices from other industries to address the needs of our clients.
About The international Society for Cell Therapy
ISCT is a global society of clinicians, regulators, technologists, and industry partners with a shared vision to translate cellular therapy into safe and effective therapies to improve patients’ lives. ISCT Members gain access to an influential global community of peers, experts, and organizations invested in cell therapy. ISCT offers a unique collaboration between academia, regulatory bodies, and industry partners in cell therapy translation.
Read more: https://www.celltherapysociety.org/events/EventDetails.aspx?id=1112470